1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. DBV Technologies
  6. News
  7. Summary
    DBV   FR0010417345

DBV TECHNOLOGIES

(DBV)
  Report
Real-time Euronext Paris  -  06:45 2022-08-10 am EDT
5.125 EUR   -0.19%
08/03Kepler Cheuvreux Upgrades DBV Technologies to Buy From Hold
MT
08/02European ADRs Move Lower in Tuesday Trading
MT
08/01DBV TECHNOLOGIES : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Wednesday Trading

06/08/2022 | 11:03am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 0.00% 2.22 Delayed Quote.-40.80%
AMARIN CORPORATION PLC -2.76% 1.41 Delayed Quote.-58.16%
AVADEL PHARMACEUTICALS PLC 15.85% 7.31 Delayed Quote.-9.53%
BICYCLE THERAPEUTICS PLC -2.89% 26.85 Delayed Quote.-55.89%
CARNIVAL CORPORATION -5.39% 9.47 Delayed Quote.-52.93%
CELLECTIS S.A. -1.43% 3.164 Real-time Quote.-56.85%
CRH PLC 0.80% 3202 Delayed Quote.-18.53%
DBV TECHNOLOGIES -0.19% 5.125 Real-time Quote.67.87%
DEUTSCHE BANK AG 0.00% 8.725 Delayed Quote.-20.79%
DIAGEO PLC -0.58% 3842.04 Delayed Quote.-4.20%
FORWARD PHARMA A/S -4.19% 3.66 Delayed Quote.-38.69%
GENFIT 0.49% 4.47 Real-time Quote.3.06%
HSBC HOLDINGS PLC 0.00% 553.4 Delayed Quote.23.37%
MORPHOSYS AG -2.17% 22.5 Delayed Quote.-31.03%
SPARK NETWORKS SE -2.24% 3.05 Delayed Quote.-2.87%
ZEALAND PHARMA A/S -2.69% 119 Delayed Quote.-15.58%
All news about DBV TECHNOLOGIES
08/03Kepler Cheuvreux Upgrades DBV Technologies to Buy From Hold
MT
08/02European ADRs Move Lower in Tuesday Trading
MT
08/01DBV TECHNOLOGIES : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/01DBV TECHNOLOGIES S.A. Management's Discussion and Analysis of Financial Condition and ..
AQ
08/01DBV Technologies Reports Second Quarter 2022 Financial Results
GL
08/01DBV Technologies Reports Second Quarter 2022 Financial Results
GL
08/01DBV Technologies S.A. Reports Earnings Results for the Second Quarter and Six Months En..
CI
08/01European ADRs Move Higher in Monday Trading
MT
08/01DBV TECHNOLOGIES : Half-year results
CO
07/27Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GL
More news
Analyst Recommendations on DBV TECHNOLOGIES
More recommendations
Financials
Sales 2022 7,16 M 7,32 M 7,32 M
Net income 2022 -90,9 M -93,0 M -93,0 M
Net cash 2022 212 M 217 M 217 M
P/E ratio 2022 -6,18x
Yield 2022 -
Capitalization 482 M 493 M 493 M
EV / Sales 2022 37,8x
EV / Sales 2023 31,8x
Nbr of Employees 87
Free-Float 91,6%
Chart DBV TECHNOLOGIES
Duration : Period :
DBV Technologies Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DBV TECHNOLOGIES
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 5,14 €
Average target price 5,75 €
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Daniel Tassé Chief Executive Officer & Executive Director
Sébastien Robitaille Chief Financial Officer
Michel de Rosen Non-Executive Chairman
Pharis Mohideen Chief Medical Officer
Pascal Wotling Chief Technical Operations Officer
Sector and Competitors
1st jan.Capi. (M$)
DBV TECHNOLOGIES67.87%493
MERCK KGAA-18.94%81 824
KYOWA KIRIN CO. LTD.0.48%12 605
SK BIOPHARMACEUTICALS CO., LTD.-15.64%4 914
BETTA PHARMACEUTICALS CO., LTD.-33.82%3 250
YUHAN CORPORATION-5.48%3 060